M. Eckhardt, E. Langkopf, M. Mark, et al. 8-(3-(R)-amino- piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes. Journal of Medicinal Chem- istry, 2007, 50(26): 6450-6453.